Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rosetta Genomics (ROSGQ)
:ROSGQ
ROSGQ Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume18.10K
Average Volume (3M)338.00
Market Cap
$593.00
Enterprise ValueN/A
Total Cash (Recent Filing)30.80M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.53
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,930,000
10 Day Avg. Volume0
30 Day Avg. Volume338
Standard Deviation22.90
R-Squared0.00186
Alpha5.65
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.15% Other Institutional Investors
99.85% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ROSGQ FAQ
What was Rosetta Genomics’s price range in the past 12 months?
Currently, no data Available
What is Rosetta Genomics’s market cap?
Rosetta Genomics’s market cap is $593.00.
When is Rosetta Genomics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rosetta Genomics’s earnings last quarter?
Currently, no data Available
Is Rosetta Genomics overvalued?
According to Wall Street analysts Rosetta Genomics’s price is currently Overvalued.
Does Rosetta Genomics pay dividends?
Rosetta Genomics does not currently pay dividends.
What is Rosetta Genomics’s EPS estimate?
Rosetta Genomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rosetta Genomics have?
Rosetta Genomics has 5,930,000 shares outstanding.
What happened to Rosetta Genomics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rosetta Genomics?
Currently, no hedge funds are holding shares in ROSGQ
---
Company Description
Rosetta Genomics
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.
---
ROSGQ Stock 12 Month Forecast
Average Price Target
―---